Literature DB >> 19052220

Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.

Suzanne Tydlacka1, Chuan-En Wang, Xuejun Wang, Shihua Li, Xiao-Jiang Li.   

Abstract

A variety of neurological disorders and polyglutamine (polyQ) diseases are caused by misfolded proteins. The common feature of these diseases is late-onset cellular degeneration that selectively affects neurons in distinct brain regions. polyQ diseases, including Huntington's disease (HD), present a clear case of selective neurodegeneration caused by polyQ expansion-induced protein misfolding, which also leads to predominant inclusions in neuronal nuclei. It remains unclear how these ubiquitously expressed disease proteins selectively kill neurons. In HD, mutant huntingtin accumulates in both neurons and glia, but more neuronal cells display huntingtin aggregates. These aggregates colocalize with components of the ubiquitin-proteasome system (UPS), which plays a critical role in clearing misfolded proteins. Using fluorescent reporters that reflect cellular UPS activity, we found that UPS activity in cultured neurons and glia decreases in a time-dependent manner. Importantly, UPS activity is lower in neurons than in glia and also lower in the nucleus than the cytoplasm. By expressing the UPS reporters in glia and neurons in the mouse brain, we also observed an age-dependent decrease in UPS activity, which is more pronounced in neurons than glial cells. Although brain UPS activities were similar between wild-type and HD 150Q knock-in mice, inhibiting the UPS markedly increases the accumulation of mutant htt in cultured glial cells. These findings suggest that the lower neuronal UPS activity may account for the preferential accumulation of misfolded proteins in neurons, as well as their selective vulnerability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052220      PMCID: PMC2662777          DOI: 10.1523/JNEUROSCI.4393-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes.

Authors:  Xin Dong; Jinbao Liu; Hanqiao Zheng; Joseph W Glasford; Wei Huang; Quan Hai Chen; Niels R Harden; Faqian Li; A Martin Gerdes; Xuejun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-22       Impact factor: 4.733

Review 2.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 3.  Proteasomes: machines for all reasons.

Authors:  George N Demartino; Thomas G Gillette
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

Review 4.  Proteasome function in aging and oxidative stress: implications in protein maintenance failure.

Authors:  Luc Farout; Bertrand Friguet
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

5.  Neurological abnormalities in a knock-in mouse model of Huntington's disease.

Authors:  C H Lin; S Tallaksen-Greene; W M Chien; J A Cearley; W S Jackson; A B Crouse; S Ren; X J Li; R L Albin; P J Detloff
Journal:  Hum Mol Genet       Date:  2001-01-15       Impact factor: 6.150

6.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 7.  Huntington's disease. Pathogenesis and management.

Authors:  J B Martin; J F Gusella
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

8.  Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.

Authors:  John S Bett; Geoffrey M Goellner; Ben Woodman; Gregory Pratt; Martin Rechsteiner; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-11-25       Impact factor: 6.150

9.  A transgenic mouse model of the ubiquitin/proteasome system.

Authors:  Kristina Lindsten; Victoria Menéndez-Benito; Maria G Masucci; Nico P Dantuma
Journal:  Nat Biotechnol       Date:  2003-07-20       Impact factor: 54.908

10.  Multiple pathways contribute to the pathogenesis of Huntington disease.

Authors:  Shihua Li; Xiao-Jiang Li
Journal:  Mol Neurodegener       Date:  2006-12-16       Impact factor: 14.195

View more
  78 in total

Review 1.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

Review 2.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

3.  Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.

Authors:  Shona Mookerjee; Theodora Papanikolaou; Stephan J Guyenet; Vanitha Sampath; Amy Lin; Cathy Vitelli; Francesco DeGiacomo; Bryce L Sopher; Sylvia F Chen; Albert R La Spada; Lisa M Ellerby
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

4.  Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes.

Authors:  Lei-lei Chen; Jun-chao Wu; Lin-hui Wang; Jin Wang; Zheng-hong Qin; Marian Difiglia; Fang Lin
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

5.  Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms.

Authors:  Jennifer Bradford; Ji-Yeon Shin; Meredith Roberts; Chuan-En Wang; Xiao-Jiang Li; Shihua Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

6.  Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation.

Authors:  H Jürgen Wenzel; Michael R Hunsaker; Claudia M Greco; Rob Willemsen; Robert F Berman
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

7.  Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime.

Authors:  Cao Huang; Pedro Yuxing Xia; Hongxia Zhou
Journal:  Int J Biol Sci       Date:  2010-07-04       Impact factor: 6.580

8.  Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP.

Authors:  Hui Yang; Chao Liu; Yongwang Zhong; Shouqing Luo; Mervyn J Monteiro; Shengyun Fang
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 9.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

Review 10.  Nuclear accumulation of polyglutamine disease proteins and neuropathology.

Authors:  Lauren S Havel; Shihua Li; Xiao-Jiang Li
Journal:  Mol Brain       Date:  2009-07-03       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.